The only immediate pathway for these dwellings to become net zero is to invest in either a zero carbon PPA or carbon offset scheme, both of which come with significant increases in the cost of purchased electricity..
Improving pharmaceutical facility design with Chips, generative design and automation.We are now using chips as the basis of generative designs to allow us to automate the design process.
In this context, generative design means using computers to assemble designs based on a set of rules, components and input parameters.We generate very large numbers of options for a particular design requirement, and then get humans back in to look at those critically.. We can generate many more options using automation.Sometimes we find something which human expertise has not spotted.
Generative design can create unexpected options with high value.. We are now working on making Chips available to very large numbers of users through a web interface, to use generative design for pharmaceutical plants.We are also associating process simulation data with those Chips, so that we can look at throughput, and use throughput to define what Chips we need..
The Chip as future enabler.
We are often asked what ‘Chip’ stands for.We envision that there is likely to be about a ten-year window of opportunity here, and the industry needs to make a start.
It also seems likely that within the grand scheme of things on the horizon, the digital work will take longer than the physical aspects, and we should be conscious of that.. Miranda Sharp reminds us that digitising planning and the wider built environment won’t be easy to do.Some of the necessary work will be boring, and it will be a grind to make the data interoperable and set the transaction mechanisms.
Aligning standards, cleaning up data and creating transformation will all take a long time.The industry wants a silver bullet, it wants to skip to the end, but there’s some fairly heavy lifting to be done first.